The US Bankruptcy Court gave an order approving the sale of certain of Athenex Pharmaceutical Division, LLC on June 27, 2023. The debtor has been authorized to sell its certain assets to Oaktree Strategic Credit Asset Holdings, LLC for a consideration of credit bid in the mount of $20 million or the product of $20 million and closing account receivables divided by $78.74 million, whichever is less. Buyer is represented by Rita-Anne O?Neill; Ari B. Blaut; Benjamin S. Beller of Sullivan & Cromwell LLP as its legal advisors.